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Abstract. The initiation of limb development depends 
on the site specific proliferation of the mesenchyme by 
the signals from the apical ectodermal ridge (AER) in 
embryonic mouse. We have previously reported that 
the local expression of Hst-1/Fgf-4 transcripts in AER 
of the mouse limb bud is developmentally regulated, 
expressed at 11 and 12 days post coitus (p.c.) embryo. 
In an effort to further understand the role of Hst-1/ 
FGF-4 in mouse limb development, an antisense oli- 
godeoxynucleotides (ODNs) study was performed. We 
first established a novel organ culture system to study 
mouse limb development in vitro. This system allows 
mouse limb bud at 9.5-10-d p.c. embryo, when placed 
on a sheet of extracellular matrix in a defined medium, 
to differentiate into a limb at 12.5-d p.c. embryo within 
4.5 d. Using this organ culture system, we have shown 
that exposure of 9.5-10-d p.c. embryonal limb bud ex- 
plants to antisense ODNs of Hst-1/FGF-4 blocks limb 
development. In contrast, sense and scrambled ODNs 
have no inhibitory effect on limb outgrowth, suggesting 
that Hst-1/FGF-4 may work as a potent inducing factor 
for mouse limb development. 
I 
N mammals, there are presently nine genes that have 
been  classified as family members  of the  fibroblast 
growth  factors  (FGFs)  1 (Delli  Bovi  and  Basillico, 
1987; Delli Bovi et al., 1987; Burgess and Maciag, 1989; 
Goldfab, 1990; Miyamoto et al., 1993). FGFs are mitogenic 
to a large number of ectodermally and mesodermally de- 
rived cells and can act as inducers of cell differentiation 
(Slack et al.,  1987; Folkman et al., 1989; DiMario et al., 
1989).  Hst-1/FGF-4 was first identified as a transforming 
gene from human stomach cancer (Sakamoto et al., 1986; 
Yoshida et al.,  1987)  and its transcript was identified in 
male germ cell tumors (Yoshida et al., 1988a) and embryo- 
nal carcinoma (EC)  cells (Yoshida et  al.,  1988b).  How- 
ever, the gene is normally silent in the normal adult tis- 
sues,  giving  rise  to  the  presumption  that  Hst-1/FGF-4 
expression is important during embryonic stage. This was 
supported by the fact that Fgf-4 gene is expressed during 
early  embryonic  development  (Niswander  and  Martin, 
1992).  Moreover, this was further bolstered by targeted 
disruption of Fgf-4 gene, which results in embryonic le- 
thality at the gastrulation stage (Feldman et al., 1995). 
In addition to its early embryonic function, Hst-1/FGF-4 
may play crucial role in later stage of development. There 
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are many reports that Hst-1/FGF-4 may act as an inducer 
of limb mesenchyme proliferation. For understanding the 
molecular mechanisms of limb development, the develop- 
ing chick limb serves as an excellent experimental system. 
FGF-2 and Hst-1/FGF-4 were used in in vivo studies of 
chick  limb  development.  Ectopic  production  of human 
FGF-2 in the  chick limb bud by using retroviral vector 
caused  formation  of  patterned  extra-skeletal  elements 
(Riley et al., 1993). If the apical ectodermal ridge (AER) is 
removed surgically, regeneration does not follow. When 
ectopic human HST-1/FGF-4  was  supplied  to the  chick 
limb bud after AER removal, limb development occurred 
normally (Niswander et al., 1993). The same effect was ob- 
served when ectopic FGF-2 was supplied to the chick api- 
cal bud mesoderm after ridge removal (Fallon et al., 1994). 
In the mouse system, we and others (Suzuki et al., 1992; 
Niswander and Martin, 1992) have reported that mouse 
Hst-1/FGF-4 is detected in 11- and 12-d post coitus (p.c.) 
embryo, where it was localized to the AER of mouse limb 
bud. The limb outgrowth seems controlled by two signal- 
ing  molecules,  HST-1/FGF-4  as  a  stimulator  and  bone 
morphogenetic factor 2 (BMP2) as an inhibitor (Niswan- 
der and Martin, 1993). Other members of the FGF family 
are also expressed in the mouse AER: FGF-8 (Ohuchi et 
al.,  1994; Crossley  and  Martin,  1995)  and  presumably 
FGF-2, although FGF-2 has only been shown to be in the 
chick limb (Savage et al.,  1993; Dono and Zeller, 1994), 
and they can provide the signals necessary for limb devel- 
opment.  Many other molecules  and  genes  such  as reti- 
noides (Bryant and Gardiner, 1992; Rutledge et al., 1994) 
and homeoboxes (Izpisfia-Belmonte et al., 1991) are incor- 
porated into the signaling pathways in the developing limb 
bud  (reviewed by Tabin,  1991, 1995; Tickle,  1991).  An- 
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hedgehog which has recently been reported to initiate ex- 
pression  of  secondary  signaling  molecules,  including 
BMP2 and HST-1/FGF-4 (Laufer et al., 1994;  Niswander 
et al., 1994). Thereby the interest lies in elucidating which 
of these genes normally functions in vivo. However, the 
lack of a  suitable in vitro culture  system for mouse limb 
development makes understanding the molecular mecha- 
nisms of mouse limb outgrowth incomplete. 
To try to directly assess the role of Hst-1/FGF-4 in limb 
development in vitro, we initially established a novel cul- 
ture system in a serum-free medium formulation for caus- 
ing mouse limb outgrowth. This culturing system not only 
allows limb outgrowth but also provides us with a suitable 
model system to explore the key factors for limb develop- 
ment by controlling a variety of culture conditions with or 
without  additives  such  as  several growth  factors,  inhibi- 
tors,  synthetic  peptides,  and  antisense  oligodeoxynucle- 
otides  (ODNs).  To investigate further the role of Hst-1/ 
FGF-4 in limb bud outgrowth, we used an ODN strategy 
in cultures of 9.5-10-d p.c. embryonic mouse limb bud ex- 
plants in a serum-free, chemically defined medium. We re- 
port here that inhibition of Hst-1/FGF-4 expression results 
in marked impairment of limb outgrowth. Our results sug- 
gest direct evidence that Hst-1/FGF-4 worked naturally as 
an inducer of mouse limb development. 
Materials and Methods 
Microdissection and Limb Organ Culture 
Pregnant dams (ICR, 7-wk-old) were obtained from Charles River Breed- 
ing Laboratories (Yokohama, Japan) and were killed by diethylether ex- 
cess on 9.5-10-d p.c. (the day on which the vaginal plug is found =  0.5-d 
p.c.). Embryos were aseptically dissected from uterine decidua and devel- 
opmentally staged by morphology of hind limb bud form, and 9.5-d p.c. 
embryos (forelimb) and 10-d p.c. embryos (hindlimb) were used for the 
experiments. The bodies of the embryos were microsurgically cut off at 
the middle of the abdomen with the head and tail trimmed away. The 
trunk fragments were placed on a sheet of extracellutar matrix (a mixture 
of 25 I~g/mi laminin, 50 p~g/ml fibronectin, 2  p,g/ml vitronectin, 1 ixg/ml 
type I and type IV collagen, 10 ixg/ml chondroitin sulfate proteoglycan, 10 
~g/ml dermatan sulfate proteoglycan, 50 ng/ml heparan sulfate proteogly- 
can) in a limb differentiation medium (DME; 10  -4 M 2-mercaptoethanol, 
200 ~M monothioglycerol, 0.8% methylcellulose, 10  -7 M selenium, 5 p~g/ml 
linoleic acid, 4 ixg/ml hydrocortisone, 5  p,g/ml transferrin) and then incu- 
bated at 37°C, 5 % CO2. All chemicals except proteoglycans (Becton Dick- 
inson & Co., Mountain View, CA) were purchased from Sigma Chemical 
Co., St. Louis, MO. As the limb bud grows it develops asymmetries along 
the anterior-posterior, dorsal-ventral, and proximal-distal (P-D) axes. At 
the end of culture, for the indication of limb outgrowth quantitatively, 
P-D length was measured under a stereoscopic microscope. To determine 
the skeletal development of limb culture, they were fixed with 10% forma- 
line, stained in 0.1%  alcian blue in 70% alcohol at 37°C for 72 h, dehy- 
drated in ethanol, and cleaned in methyl salicylate (Lyons et al., 1990). 
Cell Culture 
NIH3T3 cells transformed by mouse Hst-1/Fgf-4 gene (Sakamoto et al., 
1986) were grown at 37°C in 5% CO2 in DME containing 5% heat inacti- 
vated  calf serum  (GIBCO-BRL,  Gaithersburg,  MD).  Calf serum was 
omitted from cell culture during the treatment of oligodeoxynucleotides. 
Synthetic Oligodeoxynucleotides 
Phosphorothioate  ODNs were  synthesized with  18 mers against ATG 
translation start site (5'd-CGGCCCGCGq77FCGCCAT-3'), donor (5'd- 
AGAGCI?CCAGAAGACCTG-3'), and acceptor (5'd-CCCGCTGGCACT- 
CACCAC-3') sites for exon 2 of mouse Hst-1/Fgf-4,  respectively. As a con- 
trol, sense and scrambled ODNs were used. The most striking antisense 
effects were obtained by antisense ODNs for ATG site; a sense sequence 
of 3'd-GCCGGGCGCAAAGCGGTA-5'd, and a scrambled sequence of 
5'd-AGCTGCTGCTGCCCC-3'  were  used  as  a  negative  control.  All 
ODNs were repeatedly ethanol precipitated and were dissolved in double 
distilled water and quantitated by optical density at O17)260. 
Targeted Exposure of ODNs 
Hst-1/Fgf-4 transformed NIH3T3 cells were exposed to antisense or con- 
trol  ODNs at 500 nM with Lipofectin (GIBCO-BRL) according to the 
recommended method; ODNs were mixed with Lipofectin reagent: 1:1 
(wt/wt) liposome formulation of the DOTMA and DOPE, at a ratio of 50 
Ixl of Lipofectin/50 ~1 of 1.43 Ixg/ml ODNs (100 p2/10  s cells), and then in- 
cubated for 15 min at room temperature. The mixture was added to the 
cells and then cultured for 3 d with serum-free DME. As for limb organ 
culture, the same ODNs-Lipofectin mixture (5 jxl/site) was put directly on 
the surface of limb bud (AER region) under a  stereoscopic microscope 
(Nikon SMZ-U) and incubated for 20 min in the incubator without culture 
medium. After several washings with phosphate buffered saline to remove 
the excess ODNs-Lipofectin mixture, the limb differentiation medium 
was added to the explants, and then cultured as described. As for a rescue 
experiment, antisense ODNs bearing limbs were cultured in the limb dif- 
ferentiation  medium supplemented with  recombinant FGF-4  proteins 
(R & D Systems, Minneapolis, MN) at a final concentration of 800 ng/ml. 
Northern Hybridization Studies 
After the exposure of ODNs, 20 pairs of limb buds from the explants were 
dissociated and pooled, then total RNA was extracted. About 25 p,g of 
each RNA sample was subjected to RNA blot analysis using the full size 
of mouse Hst-1/Fgf-4 cDNA, basic FGF/Fgf-2 cDNA, and AIGF/Fgf-8 
cDNA (Tanaka et al., 1992) as a probe. As an internal reference, the same 
filter was later rehybridized to a mouse 13-aetin probe. 
Results 
Establishment of  a Novel Culture System 
for Limb Development 
As a first step toward studying the possible involvement of 
Hst-1/FGF-4 in mouse limb development, we initially es- 
tablished a  novel in vitro culture  system in a  serum-free 
medium formulation for causing mouse limb outgrowth as 
well as limb skeletal development (Fig. 1). Table I lists the 
ingredients and their concentrations for the three distinct 
media formulations used in this investigation.  All media 
formulations used DME supplemented with 20 mM Hepes, 
pH 7.4,  100 U/ml penicillin G sodium, 100 ~g/ml  strepto- 
mycin sulfate, and 5 ixg/ml amphotericin B as a basal me- 
dium. The original serum-free medium formulation (M1) 
contained six additives and was sufficient to maintain and 
allow  limb  outgrowth  (data  not  shown).  However,  the 
trunk fragments were unstable in a liquid media and often 
spoiled at the tip of limbs. To overcome this problem, al- 
ternative formulations (M2: 0.4% gelatin; M3: 0.8% meth- 
ylcellulose) were investigated. Although we did not show 
individual results, M3 formulation gave a stable result and 
greatly enhanced longevity of limb culture. Therefore we 
put the trunk fragment with limbs on a sheet of extracellu- 
lar matrix and  then  cultured  with  a  limb differentiation 
medium of M3 formulation. Under the conditions of this 
system, the  trunc  section with  forelimbs (9.5-d  p.c.)  and 
hindlimbs (10-d p.c.) (Fig. 2, A and B) was cultured for 4.5 d 
and  subsequently  stained  with  alcian  blue  to reveal the 
skeletal  pattern.  The  morphological pattern  of cultured 
forelimb and hindlimb (Fig. 2, C and D) resembled that of 
limbs from a 12.5-d p.c. embryo that developed in vivo. A1- 
cian blue staining showed that skeletal development also 
occurred normally in culture  (Fig. 2, E  and F). Thus, this 
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Figure 1.  Schematic representation of a novel culture system for 
limb development. (A) The body of the 9.5-10-d p.c. mouse em- 
bryo was cut off (broken lines indicate position of cuts: the head 
and tail trimmed away) and was placed on a sheet of extracellular 
matrix (a mixture of laminin,  25 Ixg/ml; fibronectin, 50 p~g/ml; vi- 
tronectin, 2 ixg/ml; type I and type IV collagen, 1 ixg/ml; chon- 
droitin  sulfate  proteoglycan,  10  ;xg/ml; dermatan  sulfate  pro- 
teoglycan, 10 t~g/ml; heparan sulfate proteoglycan, 50 ng/ml) in 
the limb differentiation medium (DME; 2-mercaptoethanol, 10  -4 
M; monothioglycerol, 200 ixM; methylcellulose, 0.8%; selenium, 
10  -7 M; linoleic  acid, 5 }xg/ml;  hydrocortisone, 4 ixg/ml; transfer- 
tin, 5 }xg/ml), and then incubated at 37°C, 5% CO2. (B) Targeted 
administration  of ODNs with  liposome: The  ODNs-Lipofectin 
(GIBCO-BRL) mixture (5 ill/site)  was put directly on the surface 
of limb bud and incubated for 20 min in the incubator without 
culture medium. The limb differentiation medium was added to 
the explants and then cultured as described. 
culturing  system  allows  limb  outgrowth  normally  as  in 
vivo. 
Effects of  Antisense ODNs on Transformed Phenotype 
of NIH3T3 Cells 
To  determine  the  inhibitory  effect  of  antisense  ODNs 
against  Hst-1  expression,  we  examined  the  efficiency of 
the  ODNs  as  to whether  treating  cultured  NIH3T3 cells 
transformed  via  Hst-1/Fgf-4 gene  with  antisense  ODNs 
would  make  them  revert  to  a  normal  morphology.  Syn- 
thetic  three  types  of phosphorothioate  antisense  ODNs 
against ATG translation start site, donor and acceptor site 
for exon 2 of mouse Hst-1/Fgf-4 were used at 250 nM with 
liposome  (Lipofectin)  in  cultures  of  cells  for  3  d  with 
serum-free  DME,  followed  by  evaluation  of  the  cell 
morphology. The  most striking  effects  were  obtained  by 
antisense  ODNs  against  ATG  site  (60-70%  in  repeated 
experiments);  no  significant  effect  was  observed  on  the 
other two antisense ODNs (1.5-2.0%  reversion relative to 
untreated cells). The greatest response  (I>90% reversion) 
was attained when antisense ODNs against ATG site were 
administered with Lipofectin at a dose of 500 nM (Fig. 3). 
Figure 2.  Limb development in vitro. Right forelimb bud from 
the mouse embryo at 9.5-d p.c.  (A) and hindlimb bud from the 
mouse embryo at 10-d p.c. (B). Cultured right forelimb (C) and 
hindlimb (D) in the limb differentiation medium for 4.5 d as de- 
scribed above. They were fixed in 10% formalin, stained in 0.1% 
Atcian blue in 70% acid alcohol at 30°C for 72 h, dehydrated in 
ethanol, and cleaned in methyl salicylate:  right forelimb (E) and 
hindlimb (F). 
Contrarily,  the same  sense  and scrambled  ODNs against 
ATG site used as control revealed no effect. None of the 
synthetic  ODNs  at  500  nM  increased  the  positivity  of 
stained  cells  with  trypan  blue  exclusion  test  during  the 
course of the experiment, suggesting that the inhibitory ef- 
fects  of antisense  ODNs were  not due  to cytotoxicity of 
the  synthetic  ODNs.  The  flat revertant  induced  by anti- 
sense ODNs returned to the original spindle shape after 5 d 
in culture unless there was a further supply of fresh ODNs 
into the culture medium (data not shown). 
Antisense Inhibition of Hst-1/Fgf-4  mRNA of the 
Cultured Limbs 
The  presence  of Hst-1/Fgf-4 mRNA  in  the  explants  of 
forelimb bud at 9.5-d p.c.  embryo was detected  1.5-2.5  d 
after the in vitro culture  and diminished  thereafter  (data 
not shown).  To  ascertain  whether  treatment  with  Hst-1/ 
FGF-4 antisense  ODNs caused a  decrease in the amount 
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Development 
Medium concentration 
Supplement  M  1  M2  M3 
2-mercaptoethanol  10  -4 M  10  -4 M  10  -4 M 
Monothioglycerol  200 IxM  200 ixM  200 ~M 
Selenium  10  -7 M  10  -7 M  10  -7 M 
Linoleic acid  5 ~g/ml  5 Ixg/ml  5 ~g/ml 
Hydrocortisone  4 ~xg/ml  4 p.g/ml  4/xg/ml 
Transferrin  5 ixg/ml  5 txg/ml  5 Ixg/rnl 
Gelatin  -  0.4%  - 
Methylcellulose  -  -  0.8 % 
All media  formulations  used DME supplemented  with Hepes,  pH 7.4, 100 U/ml  penicil- 
lin G. 100 irg/ml  streptomycin  sulfate, and 5 Ixg/ml  amphotericin  B as a basal medium. 
of mRNA of Hst-1/Fgf-4  in the mouse limb bud quantita- 
tively, total RNAs were prepared from a pool of limb buds 
treated with ODNs for 2.5 d, and then RNA blot hybrid- 
ization  was  performed.  An  extremely  small  amount  of 
Hst-1/FGF-4  transcript  was  detected  in  RNA  isolated 
from limb buds exposed to Hst-1/FGF-4 antisense  ODNs, 
a >90% reduction compared to untreated control (Fig. 4) ; 
in  contrast,  the  expression  of endogeneous  13-actin  was 
clearly detectable  without reduction, indicating the selec- 
tive  reduction  of Hst-1/FGF-4  transcripts.  Other  control 
ODNs  showed no apparent  effect on the  level  of Hst-1/ 
FGF-4  transcripts.  In addition,  we  tested  the  amount  of 
transcripts from a molecule closely related to Hst-1/FGF-4 
such as FGF-2 and FGF-8, which are also expressed in the 
limbs of early embryonic stage. As shown in Fig. 4, no ap- 
parent  inhibitory effect on FGF-2  and FGF-8 transcripts 
was detected.  Overall, these results suggest that antisense 
ODNs against ATG translation  start  site  of Hst-1/FGF-4 
significantly alter the degree of Hst-1/FGF-4 expression in 
a  sequence-dependent  manner  in  the  limb  bud  cultures 
without any cytotoxic effects. 
Hst-IlFGF-4 Antisense ODNs Block Limb 
Development In Vitro 
By using this  novel organ culture  system, we treated  the 
9.5-10-d  p.c.  embryo with  antisense  ODNs  complemen- 
tary to mouse Hst-1/Fgf-4  gene for 4.5  d. This  treatment 
resulted  in  the  blocking  of forelimb  and  hindlimb  out- 
growth (Fig.  5, A  and B).  On the  contrary, sense  ODNs 
have no inhibitory effects (Fig. 5, C and D). Measurements 
of the  P-D  length  of antisense  ODNs  treated  forelimbs 
and  hindlimbs  showed  that  the  embryonic  stage  was 
slightly  advanced,  most  like  the  10.5-d  p.c.  embryonal 
limbs in vivo and then their growth was stopped as sum- 
marized in Table II. 
In a separate  experiment, Hst-1/FGF-4 antisense  ODN- 
treated  limbs  were  cultured  in  limb  differentiation  me- 
dium supplemented with recombinant human FGF-4 pro- 
teins (800 ng/ml). As shown in Table II, exogenous FGF-4 
protein rescued outgrowth (P-D length) of limbs from the 
inhibitory effect of antisense ODNs (-,~80%  rescued in P-D 
length relative  to antisense  ODNs-treated  forelimbs  and 
hindlimbs).  Furthermore,  to verify that inhibition of limb 
development by antisense ODNs does not correspond to a 
cytotoxic effect of ODNs,  limb  culture  was examined  by 
trypan blue exclusion test 2.0 and 4.5 d  after the addition 
of antisense  ODNs  and compared to untreated  limb  cul- 
ture.  Although data is not shown,  specific cell death was 
not detected  in antisense  ODNs-treated  limbs  at day 2.0 
nor day 4.5  in culture.  These  results  indicated  direct evi- 
dence that Hst-1/FGF-4 expression is critical for the induc- 
tion of mouse limb outgrowth. 
Discussion 
Although  we  originally  identified  the  Hst-1/Fgf-4  as  a 
transforming oncogene  on transfection  assay of NIH3T3 
cells (Sakamoto et al.,  1986), we have subsequently noted 
that mouse Hst-1/FGF-4 is also expressed on cells of AER 
in developing mouse limb bud (Suzuki et al., 1992). Hst-1/ 
FGF-4 expression reaches  a  peak 11-12-d p.c. in the em- 
bryonal limbs  and  then  disappears  as  limb  development 
progresses 16-d p.c. in forelimb bud. Several genes are ex- 
pressed in the mouse AER other than Hst-1/Fgf-4,  includ- 
ing Fgf-2 and Fgf-8. However, it has not yet been possible 
to determine  which of these  genes normally functions in 
vivo. In addition to the fact that there are no classical mu- 
Figure 3.  Effect  of  antisense 
ODNs  on  Hst-1/Fgf-4 trans- 
formed NIH3T3 cells. NIH3T3 
cells  transformed  by  mouse 
Hst-1/Fgf-4 gene (A)  showed 
malignant  phenotype  with 
spindle  shape.  They were  ex- 
posed to antisense (B) or con- 
trol sense (C) ODNs at 500 nM 
with  Lipofectin  according  to 
the  recommended  method 
and then cultured for 3 d with 
5%  heat-inactivated  calf  se- 
rum-DME.  Hst-1/FGF-4  anti- 
sense  ODNs:  5'd-  CGGCCC- 
GCGTITCGCCAT-3';  control 
sense  ODNs:  5'd-ATGGC- 
GAAACGCGGGCCG-3';  con- 
trol scrambled ODNs: 5'd-AGC- 
TGCTGCTGCTGCCCC-3'. 
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to antisense  ODNs. ODNs were administered to the limb bud as 
described in Fig. 1 B at a final concentration  of 500 nM for 2.5 d in 
culture. At the end of the incubation period, 20 pairs of limb buds 
were pooled and then total mRNAs were extracted. About 25 p.g 
of each RNA sample was subjected to RNA blot analyses using 
full  size  of mouse Hst-1/Fgf-4 cDNA, Fgf-2 cDNA,  and Fgf-8 
cDNA as a probe. Lane 1, untreated forelimb buds; lane 2, Hst-1/ 
FGF-4 antisense  ODNs treated forelimb buds;  lane 3,  control 
sense  ODNs  treated forelimb buds;  lane  4, control  scrambled 
ODNs treated forelimb buds. Treatment with ODNs did not af- 
fect the expression of 13-actin transcripts. 
tations of Fgf-4, targeted disruption of mouse Fgf-4 gene 
results in early embryonic lethality (Feldman et al., 1995), 
indicating  that FGF-4 knock-out mice could not provide 
any insights into the role of Hst-1/FGF-4 on limb develop- 
ment. Thus its role in mouse limb development can not be 
studied by conventional genetic methods. 
Our results provide direct evidence that specific expres- 
sion of Hst-1/FGF-4 is required during limb development. 
We found that antisense Hst-1/FGF-4 ODNs treatment of 
embryonic mouse  limb bud  resulted  in  a  retardation  of 
limb outgrowth, which was accompanied by a specific de- 
struction  of Hst-1/FGF-4  translation.  The  expression  of 
other FGF family members such as Fgf-2 and Fgf-8 were 
not affected by Hst-1/FGF-4 antisense ODNs. Therefore, 
among FGF genes, it is conceivable that Hst-1/Fgf-4 plays 
a major role as a positive signal for mesenchyme prolifera- 
tion of the mouse limb. 
One of the critical problems for studying the signals that 
direct limb outgrowth is a lack of a suitable in vitro system 
except for the chick developing limb system in ovo. Here 
we  established  a  novel in  vitro culture  system in  which 
mouse limb bud at 9.5-10-d p.c. embryo placed on a sheet 
of extracellular matrix in a defined medium differentiates 
into a limb at 12.5-d p.c. embryo within 4.5 d. Our cultur- 
ing system is superior to the ordinary method in that it en- 
ables further and more nearly normal limb development 
as in vivo. Our culture system reported here may provide a 
good  clue  toward  understanding  the  molecular  basis  of 
limb development including tissue-specific differentiation, 
control of cell growth, and cell to cell communication by 
controlling a variety of culture conditions with or without 
additives  such  as  several growth  factors,  inhibitors,  syn- 
thetic  peptides,  and  ODNs.  Recently,  it  has  been  sug- 
gested that BMP2 (Wang et al., 1988; Wozney et al., 1988) 
keeps  the  mesenchyme  undifferentiated  (Lyons  et  al., 
1990;  Niswander and Martin,  1993)  and controls pattern- 
ing in the developing chick limb (Francis et al., 1994).  In 
addition, it has been shown that N-cadherin is expressed in 
limb mesenchyme and pertubation of N-cadherin function 
significantly inhibits both limb mesenchymal aggregation 
and chondrogenesis in chick (Oberlender and Tuan, 1994). 
Moreover, recent  progress suggests  that Sonic hedgehog 
signals regulate expression of both BMP2 and Fgf-4 gene 
(Laufer et al., 1994). In this connection, it may be of some 
interest to see whether those molecules have a regulatory 
effect on limb development in our system. Another inter- 
est in limb development is the apoptotic process which en- 
ables digit formation. When we kept the forelimb explant 
(9.5-d p.c.) in culture for 10-12 d with one change of limb 
differentiation media containing serum (10% horse serum/ 
10% fetal calf serum) it became most like the forelimb of 
the  14.5-d p.c. embryo (unpublished data). The digit for- 
mation was observed as normal, suggesting that our sys- 
tem will be useful in studying molecular aspects of apopto- 
sis on limb development. 
Recently, several antisense ODNs studies have reported 
inhibition of tooth (Kronmiller et al., 1991;  Diekwisch et 
al.,  1993),  kidney  (Sariola  et  al.,  1991),  heart  (Runyan, 
1991),  muscle (Biro et al.,  1993),  and lung  (Souza et al., 
1994).  In general, a  rigid control is required  in antisense 
experiments. At first, the toxicity of individual batches of 
ODNs was tested on the cultured cells before they were 
put on the limb culture and it was shown that every batch 
of ODNs has no cytotoxic effect up to 10 IxM. Actually, as 
shown in Fig. 4, the expression of the house-keeping actin 
gene in the limb bud was not affected by antisense ODNs. 
Second, although data are not shown, the inhibition of the 
transformed  phenotype  by  addition  of  antisense  ODNs 
was reversible,  indicating  that  the  phenotypic change  of 
cells was not due to the cytotoxic effect of ODNs. Third, 
we designed phosphorothioate modified ODNs of 18 mers 
targeted against sequences adjacent to the ATG initiation 
codon of mouse Hst-1/Fgf-4  mRNA. Many other investi- 
gators  have  suggested  that  antisense  ODNs  against  se- 
quences adjacent to initiation codons are most effective in 
inhibiting translation  (Shakin-Esheleman and Liebhaber, 
1988;  Malcom, 1992).  Actually, in our experiments,  anti- 
sense ODNs  targeted to  sequences  other than  the  ATG 
site proved less efficient. Fourth, a recent paper has indi- 
cated that phosphorothioate  ODNs may bind directly to 
FGF-2 and possibly FGF-4, and that this may inhibit their 
function (Guvakova et al., 1995).  As shown in Fig. 5 and 
Table II, control sense  and  scrambled phosphorothioate 
ODNs did not show any inhibitory effect on limb develop- 
ment. In addition, although we did not mention the results, 
we examined the inhibitory effect of non-phosphorothio- 
ate Hst-1/FGF-4 antisense  ODNs against ATG start site. 
The  transforming  phenotype  of Hst-1/Fgf-4  transformed 
NIH3T3 cells was efficiently inhibited at 0.1-2 ixM by non- 
phosphorothioate antisense ODNs, suggesting that the in- 
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structure nor chemical modification of oligos such as phos- 
phorothioate linkages. Fifth, the fact that Hst-1/FGF-4 an- 
tisense  ODNs did not alter the expression of FGF-2 and 
FGF-8 on mouse limb bud ensures that the inhibition of 
limb development by Hst-1/FGF-4 antisense ODNs is a se- 
quence-specific effect. Lastly, inhibition of limb outgrowth 
by antisense ODNs was rescued when exogenous recombi- 
nant FGF-4 was supplied  to the limb culture,  indicating 
that antisense inhibition is not a non-specific cytotoxic ef- 
fect. Therefore our antisense experiments are adequate to 
make  a  conclusion that  Hst-1/FGF-4 is  critical  for limb 
outgrowth. 
Our ODNs-transfer method is different from the widely 
used methods of simply adding ODNs into the culture me- 
dium in that we administered  ODNs with a  form of cat- 
ionic liposome complexes. These complexes are well ab- 
Table IL Effects of list-1 Antisense ODNs on P-D Length of 
Cultured Limbs 
Length of limb in nun (mean --_ SD) 
ODNs  Forelimbs  Hindlimbs 
None  1.304 ___ 0.05  1.608 ±  0.06 
Antisense  0.580 ±  0.10  0.702 ±  0.10 
Sense  1.312 __- 0.05  1.588  ±  0.05 
Scrambled  1.289 -~ 0.10  1.600 __+ 0.10 
Antisense +  FGF-4*  1.012 ±  0.25  1.204 ___ 0.15 
Trunc  fragments with limbs (9.5-10-d p.c. embryo) were treated with ODNs as de- 
scribed and cultured on matrix gel for 4.5 d in M3 limb differentiation medium. Mea- 
surements of the P-D length were made for each pair of limbs. Number of forelimb or 
hindlimb pairs analyzed =  30. 
*Recombinant FGF-4 protein was added to the culture medium (800 ng/ra]) of anti- 
sense ODN-treated limbs and cultured for 4.5 d.  Number of forelimb or hindlimb 
pairs analyzed =  6. 
Figure  5.  Hst-1/FGF-4  anti- 
sense ODNs block limb de- 
velopment  in  vitro.  ODNs 
treatment  was performed  as 
described in Fig. 4. and then 
treated  limbs were  cultured 
for 4.5 d in vitro. Antisense 
ODNs treated  right forelimb 
(A)  and  hindlimb  (B); con- 
trol  sense ODNs  treated 
right forelimb (C) and hind- 
limb (D). Although data are 
not shown, control scrambled 
ODNs result in no inhibitory 
effects on limb outgrowth. 
sorbed  into  the  cultured  explants  without  any  great 
diffusion when placed on the desired small area and then 
are  highly  incorporated  into  the  cells.  Therefore,  one 
could introduce ODNs in a site-specific manner. Further- 
more, the liposome transfer method makes it possible to 
use nanomolar amounts of ODNs which were almost 100 
less  as compared to not using liposome. This means that 
we can see the effects of antisense ODNs with less cyto- 
toxicity. 
In summary, the results of our studies indicate that the 
Hst-1/Fgf-4 gene product is essential for embryonic limb 
outgrowth in mice. Similar antisense strategies can be pos- 
sibly used to clarify the functions of many other growth 
factors/cytokines and  their  receptors  on embryonic limb 
development by using our novel mouse limb culture system. 
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